TrialThe Korean journal of internal medicine2017

24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension.

Hae-Young Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.